Clinical Trial Update: Statin for Immunomudulation in Sepsis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a statin for immunomodulation in sepsis. The current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Statin (statin)

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Sepsis | Phase 2 | Status: UNKNOWN